NEW YORK, Dec. 15, 2016 /PRNewswire/ -- RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics. Globally increasing R&D activities in the field of RNAi activities is expected to be the key growth driver during the period of study.
Geographically North America dominated RNAi technology market owing to the large scale of its pharmaceutical industry which invests heavily in R&D activities to formulate and update new therapies. North America was followed by Europe and Asia-Pacific as second and third largest market for RNAi technology market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing pharmaceutical industrial infrastructure which has attracted many global industry player, government initiatives and in developing nations such as China, and India in this region.
This report identifies the global RNAi technology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global RNAi technology market.
This report segments global RNAi technology market on the basis of application, tools and regional market as follows:
RNAi Technology Market research report is classified on the basis of applications of RNAi technology in wide range of industries some of the major applications of RNAi Technology covered in this report are as follows: Research and Development, Therapeutics, Drug Discovery, Agriculture and Others
RNAi technology market research report is classified on the basis of tools of RNAi technology in wide range of industries some of the major applications of RNAi technology covered in this report are as follows: Design/Software, Delivery Based, Monitoring, Libraries
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the RNAi technology market. Some of the major companies' profiles in detail are as follows:
F. Hoffmann-La Roche AG
Arrowhead research corporation
Quark pharmaceuticals inc
Rxi pharmaceuticals corp.
Read the full report: http://www.reportlinker.com/p04399319-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ribonucleic-acid-interference-rnai-technology-market-by-application-research-and-development-therapeutics-drug-discovery-agriculture-by-tools-designsoftware-delivery-based-monitoring-libraries--by-region-forecast--300379602.html